Clik here to view.
Opinion: Astra-Zeneca and a Fairer Society
The approach by Pfizer to acquire Astra-Zeneca raises yet again the question of what criteria should be used to evaluate the merits of large international corporate acquisitions. I would argue that...
View ArticleClik here to view.
Huppert on Astra Zeneca takeover’s threat to jobs, the European elections and...
Julian Huppert has been talking to Cambridge student magazine Varsity. Not surprisingly, the subject of Pfizer’s proposed takeover of Astra Zeneca came up. Why should students be bothered? It will have...
View ArticleClik here to view.
Opinion: Astra-Zeneca and a Fairer Society
The approach by Pfizer to acquire Astra-Zeneca raises yet again the question of what criteria should be used to evaluate the merits of large international corporate acquisitions. I would argue that...
View ArticleClik here to view.
Huppert on Astra Zeneca takeover’s threat to jobs, the European elections and...
Julian Huppert has been talking to Cambridge student magazine Varsity. Not surprisingly, the subject of Pfizer’s proposed takeover of Astra Zeneca came up. Why should students be bothered? It will have...
View ArticleClik here to view.
Opinion: Astra-Zeneca and a Fairer Society
The approach by Pfizer to acquire Astra-Zeneca raises yet again the question of what criteria should be used to evaluate the merits of large international corporate acquisitions. I would argue that...
View ArticleClik here to view.
Huppert on Astra Zeneca takeover’s threat to jobs, the European elections and...
Julian Huppert has been talking to Cambridge student magazine Varsity. Not surprisingly, the subject of Pfizer’s proposed takeover of Astra Zeneca came up. Why should students be bothered? It will have...
View Article
